From: The challenge of durable brain control in patients with brain-only metastases from breast cancer
Median age, range (years) | 58, 37–82 |
Median KPS, range | 80, 50–100 |
KPS 80–100 vs. 70 vs. <70 (%) | 80, 16, 4 |
Single brain metastasis (%) | 24 |
More than 3 brain metastases (%) | 60 |
Infratentorial metastases only/supratentorial metastases only/botha (%) | 20, 40, 40 |
Controlled primary tumor (%) | 88 |
Triple-negative tumor (%) | 32 |
HER2 positive and ER/PR negative (%) | 32 |
HER2 positive and ER or PR positive (%) | 8 |
Headache (%) | 28 |
Ataxia (%) | 28 |
Dizziness (%) | 32 |
Coordination deficit (%) | 12 |
Visual disturbance (%) | 12 |
Seizures (%) | 16 |
Motor deficit (%) | 16 |
Speech disturbance (%) | 36 |
Cognitive deficit (%) | 24 |
Asymptomatic (%) | 8 |